$CRIS 4 SEC Filings

Filed On	Filing
09 Jul 2026	Form 4: Rubin Marc, Director Granted 6,800 Non Qualified Stock Option ($36K)
09 Jul 2026	Form 4: Kaitin Kenneth I, Director Granted 6,800 Non Qualified Stock Option ($36K)
09 Jul 2026	Form 4: Hohneker John, Director Granted 6,800 Non Qualified Stock Option ($36K)
09 Jul 2026	Form 4: Greenacre Martyn D, Director Granted 6,800 Non Qualified Stock Option ($36K)
09 Jul 2026	Form 4: Borgman Anne Elizabeth, Director Granted 6,800 Non Qualified Stock Option ($36K)
09 Jul 2026	Form 4: Duvall Diantha, CFO Granted 48,285 Employee stock option (right to buy) ($255K)
09 Jul 2026	Form 4: Zung Jonathan B., CDO Granted 48,285 Employee stock option (right to buy) ($255K)
09 Jul 2026	Form 4: Dentzer James E, Director Granted 110,090 Employee stock option (right to buy) ($582K)
01 Apr 2026	Form 4: Kaitin Kenneth I, Director Bought 10,000 shares ($5.49K)
23 Mar 2026	Form 4: Zung Jonathan B., CDO Received 66,667 shares by conversion
23 Mar 2026	Form 4: Hamdy Ahmed Md, CMO Received 66,667 shares by conversion
23 Mar 2026	Form 4: Duvall Diantha, CFO Received 66,666 shares by conversion
23 Mar 2026	Form 4: Dentzer James E, Director Received 133,333 shares by conversion
23 Mar 2026	Form 4: Rubin Marc, Director Received 26,667 shares by conversion
18 Mar 2026	Form 4: Zung Jonathan B., CDO Granted 50 Series B Convertible Preferred Stock · Granted 66,667 Series A Warrant (right to buy) · Granted 66,667 Series B Warrant (right to buy) · 1 more
18 Mar 2026	Form 4: Hamdy Ahmed Md, CMO Granted 50 Series B Convertible Preferred Stock · Granted 66,667 Series A Warrant (right to buy) · Granted 66,667 Series B Warrant (right to buy) · 1 more
18 Mar 2026	Form 4: Duvall Diantha, CFO Granted 50 Series B Convertible Preferred Stock · Granted 66,666 Series A Warrant (right to buy) · Granted 66,666 Series B Warrant (right to buy) · 1 more
18 Mar 2026	Form 4: Dentzer James E, Director Granted 100 Series B Convertible Preferred Stock · Granted 133,333 Series A Warrant (right to buy) · Granted 133,333 Series B Warrant (right to buy) · 1 more
18 Mar 2026	Form 4: Rubin Marc, Director Granted 20 Series B Convertible Preferred Stock · Granted 26,667 Series A Warrant (right to buy) · Granted 26,667 Series B Warrant (right to buy) · 1 more
22 May 2025	Form 4: Dentzer James E, Director Granted 360,000 Employee stock option (right to buy) ($1.13M)

Comments